APP and Alzheimer disease: Studies on transgenic mice carrying AD-linked mutations in the gene for APP demonstrated the existence of soluble Aβ oligomers long before the deposition of β-amyloid, further supporting the hypothesis that in particular conditions, an over-production of soluble Aβ aggregates occurs in the human brain even in the absence of plaques.